Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

ADF Inhibitors

ADF (Actin Depolymerizing Factor) inhibitors are a class of chemical compounds that play a pivotal role in the regulation of cytoskeletal dynamics within cells. The actin cytoskeleton is a complex network of protein filaments that provides structural support and facilitates various cellular processes, including cell motility, division, and shape maintenance. ADF proteins are key regulators of actin dynamics as they modulate the polymerization and depolymerization of actin filaments. ADF inhibitors, as the name suggests, are substances that impede the function of ADF proteins, thereby affecting the dynamic assembly and disassembly of actin filaments.

These inhibitors typically target ADF proteins by binding to specific regions of these proteins or by interfering with their enzymatic activity. By doing so, they disrupt the delicate balance between actin polymerization and depolymerization, leading to alterations in the cytoskeletal structure and cellular morphology. ADF inhibitors are invaluable tools in cell biology research, as they allow scientists to manipulate and study the actin cytoskeleton's dynamics with precision. Understanding the role of ADF inhibitors in controlling actin dynamics can provide insights into fundamental cellular processes, such as cell migration, cell division, and cell signaling. Additionally, this knowledge can have broader implications in fields like cancer biology, neurobiology, and developmental biology, where actin dynamics are critical for normal cellular function.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ticagrelor

274693-27-5sc-472972
sc-472972A
sc-472972B
sc-472972C
10 mg
25 mg
50 mg
100 mg
$104.00
$228.00
$270.00
$302.00
(0)

Blocks the P2Y12 receptor on platelets, preventing platelet activation and aggregation, thus inhibiting clot formation.

Clopidogrel

113665-84-2sc-507403
1 g
$122.00
1
(0)

After conversion in the liver, it irreversibly inhibits the P2Y12 receptor, reducing platelet activation and aggregation.

Prasugrel

150322-43-3sc-391536
100 mg
$79.00
(0)

Similar to clopidogrel, it's metabolized to an active form that irreversibly inhibits the P2Y12 receptor on platelets.

Dipyridamole

58-32-2sc-200717
sc-200717A
1 g
5 g
$31.00
$102.00
1
(1)

Increases levels of cAMP, inhibiting platelet activation, and also dilates blood vessels to reduce clot formation.

Rivaroxaban

366789-02-8sc-208311
2 mg
$158.00
18
(1)

Blocks the active site of factor Xa, reducing thrombin formation and preventing blood clot formation.

Apixaban

503612-47-3sc-364406
sc-364406A
10 mg
50 mg
$240.00
$634.00
2
(1)

Selectively inhibits factor Xa, thereby reducing the conversion of prothrombin to thrombin and inhibiting clot formation.

Edoxaban

480449-70-5sc-483508
25 mg
$522.00
(0)

Similar to apixaban, it specifically inhibits factor Xa to prevent thrombin generation and blood clot formation.

Fondaparinux

104993-28-4sc-507424
10 mg
$297.00
(0)

Binds to antithrombin III, enhancing its ability to inhibit factor Xa and preventing thrombin formation.

Argatroban

74863-84-6sc-201310
sc-201310A
10 mg
50 mg
$117.00
$469.00
13
(1)

Directly inhibits thrombin (factor IIa), preventing the conversion of fibrinogen to fibrin and clot formation.

Bivalirudin

128270-60-0sc-278793
5 mg
$110.00
(0)

Also a direct thrombin inhibitor, it binds to and inhibits thrombin's activity, preventing clot formation.